Blijlevens NM - Search Results

1

van der Velden WJ, Mori T, Stevens WB, de Haan AF, Stelma FF, Blijlevens NM, Donnelly JP. van der Velden WJ, et al. Among authors: blijlevens nm. Bone Marrow Transplant. 2013 Nov;48(11):1465-71. doi: 10.1038/bmt.2013.84. Epub 2013 Jun 10. Bone Marrow Transplant. 2013. PMID: 23749107

2

Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview.

Blijlevens NM, Donnelly JP, De Pauw BE. Blijlevens NM, et al. Bone Marrow Transplant. 2000 Jun;25(12):1269-78. doi: 10.1038/sj.bmt.1702447. Bone Marrow Transplant. 2000. PMID: 10871732 Free PMC article. Review.

3

Procalcitonin does not discriminate infection from inflammation after allogeneic bone marrow transplantation.

Blijlevens NM, Donnelly JP, Meis JF, De Keizer MH, De Pauw BE. Blijlevens NM, et al. Clin Diagn Lab Immunol. 2000 Nov;7(6):889-92. doi: 10.1128/CDLI.7.6.889-892.2000. Clin Diagn Lab Immunol. 2000. PMID: 11063493 Free PMC article.

4

Empirical therapy of febrile neutropenic patients with mucositis: challenge of risk-based therapy.

Blijlevens NM, Donnelly JP, de Pauw BE. Blijlevens NM, et al. Clin Microbiol Infect. 2001;7 Suppl 4:47-52. doi: 10.1046/j.1469-0691.2001.00058.x. Clin Microbiol Infect. 2001. PMID: 11688534 Free article. Review.

5

Impaired gut function as risk factor for invasive candidiasis in neutropenic patients.

Blijlevens NM, Donnelly JP, de Pauw BE. Blijlevens NM, et al. Br J Haematol. 2002 May;117(2):259-64. doi: 10.1046/j.1365-2141.2002.03394.x. Br J Haematol. 2002. PMID: 11972507 Free article. Review. No abstract available.

6

Aspergillus galactomannan antigen levels in allogeneic haematopoietic stem cell transplant recipients given total parenteral nutrition.

Blijlevens NM, Donnelly JP, Meis JF, Verweij PE, de Pauw BE. Blijlevens NM, et al. Transpl Infect Dis. 2002 Jun;4(2):64-5. doi: 10.1034/j.1399-3062.2002.00015.x. Transpl Infect Dis. 2002. PMID: 12220241

7

Can anything be done about oral mucositis?

Donnelly JP, Blijlevens NM, Verhagen CA. Donnelly JP, et al. Among authors: blijlevens nm. Ann Oncol. 2003 Apr;14(4):505-7. doi: 10.1093/annonc/mdg179. Ann Oncol. 2003. PMID: 12649093 Free article. No abstract available.

8

Monitoring cyclosporine using blood drawn via a central venous catheter.

Donnelly JP, Blijlevens NM, Schattenberg AV. Donnelly JP, et al. Among authors: blijlevens nm. Bone Marrow Transplant. 2003 Nov;32(10):1037. doi: 10.1038/sj.bmt.1704273. Bone Marrow Transplant. 2003. PMID: 14595394 No abstract available.

9

Role of curcumin and the inhibition of NF-kappaB in the onset of chemotherapy-induced mucosal barrier injury.

van't Land B, Blijlevens NM, Marteijn J, Timal S, Donnelly JP, de Witte TJ, M'Rabet L. van't Land B, et al. Among authors: blijlevens nm. Leukemia. 2004 Feb;18(2):276-84. doi: 10.1038/sj.leu.2403233. Leukemia. 2004. PMID: 14671640

10

Measuring mucosal damage induced by cytotoxic therapy.

Blijlevens NM, van't Land B, Donnelly JP, M'Rabet L, de Pauw BE. Blijlevens NM, et al. Support Care Cancer. 2004 Apr;12(4):227-33. doi: 10.1007/s00520-003-0572-3. Epub 2004 Jan 30. Support Care Cancer. 2004. PMID: 14752625

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters